Hodgkin Lymphoma News and Research

RSS
Attaching transferrin to nanoparticle surface can kill cancer cells

Attaching transferrin to nanoparticle surface can kill cancer cells

NCCN enters into collaboration to introduce Proventys CDS Oncology system

NCCN enters into collaboration to introduce Proventys CDS Oncology system

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

ASH to honor six scientists for treatment of hematologic diseases

ASH to honor six scientists for treatment of hematologic diseases

Survival rates of nine types of cancer in Spain

Survival rates of nine types of cancer in Spain

Plexxikon announces promising preclinical data of PLX3397

Plexxikon announces promising preclinical data of PLX3397

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

New study on impact of bortezomib on mantle cell lymphoma

New study on impact of bortezomib on mantle cell lymphoma

Biovest’s publicly-traded shares quoted on newly launched OTCQB Market

Biovest’s publicly-traded shares quoted on newly launched OTCQB Market

Study results show no improvement in overall survival for combination of gemcitabine and Amplimexon

Study results show no improvement in overall survival for combination of gemcitabine and Amplimexon

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

Multicolor quantum dots can distinguish Reed-Sternberg cells, article shows

Multicolor quantum dots can distinguish Reed-Sternberg cells, article shows

CTI submits expanded PIP to EMEA for pixantrone MAA for relapsed or refractory, aggressive NHL

CTI submits expanded PIP to EMEA for pixantrone MAA for relapsed or refractory, aggressive NHL

Heart patients treated for lymphoma at increased risk of cardiac problems

Heart patients treated for lymphoma at increased risk of cardiac problems

HL patients with heart disease at increased risk of hospitalization for cardiac complications after treatment

HL patients with heart disease at increased risk of hospitalization for cardiac complications after treatment

Calistoga Pharmaceuticals closes $40 million Series C financing

Calistoga Pharmaceuticals closes $40 million Series C financing

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Cell>Point completes cancer diagnostic phase 2 trial; reports favorable trends in primary tumor imaging

Cell>Point completes cancer diagnostic phase 2 trial; reports favorable trends in primary tumor imaging

MorphoSys, Xencor sign worldwide exclusive license, collaboration agreement for XmAb5574 antibody program

MorphoSys, Xencor sign worldwide exclusive license, collaboration agreement for XmAb5574 antibody program

Sanofi-aventis' Phase I clinical trial with SAR650984 triggers $1M milestone payment to ImmunoGen

Sanofi-aventis' Phase I clinical trial with SAR650984 triggers $1M milestone payment to ImmunoGen

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.